---
title: "Medicine"
author: "Susmit"
date: "`r Sys.Date()`"
documentclass: memoir
output: pdf_document
fontsize: 12pt
geometry: margin=2cm
colorlinks: true
linkcolor: blue
urlcolor: red
toccolor: gray
---

\openany
\raggedbottom
\twocoltocetc
\tableofcontents

\pagebreak


# Cardiology
## Presenting problems in CVS disease
### Features of benign murmur
- Soft
- Midsystolic
- Heard at left sternal edge
- No radiation
- No other cardiac abnormalities

## ECG
### Anatomy of an ECG
\includegraphics[width=0.7\textwidth]{../assets/ecg-anatomy.jpg}

### Abnormalities of components
#### Pathological Q
- Depth > 2mm
- Height > 1mm
- Present in $\ge$ 2 leads
- Assocd with loss of R height (Q > R/4; normally Q $\le$ R/4)
- **Indicates _transmural_ myocardial necrosis**

#### Segments vs intervals
- e.g. ST segment = end of S $\rightarrow$ start of T
- PR interval = start of P $\rightarrow$ start of R

#### ST segment elevation
- Normal: upto 1mm in limb leads, upto 2mm in chest leads
- **Causes**
	- **STEMI:** **convexity** upwards
	- **Acute periCArditis:**: **conCAvity** upwards
- **Indicates ongoing myocardial injury**

### Myocardial infarction
[A somewhat interesting physiological explanation on how the changes arise](
	https://www.cvphysiology.com/CAD/CAD012
)

#### Sites of infarction based on lead
- Septal: V$_1$, V$_2$
- Anterior: V$_3$, V$_4$
- Lateral: I, aVL, V$_5$, V$_6$
- Extensive anterior: V$_1$-V$_6$
- Anterolateral: I, aVL, V$_1$-V$_6$

#### Reciprocal changes
- Acute STEMI in some surface of the heart $\rightarrow$ ST elevation in
 corresponding leads, and ST depression in reciprocal leads 
 
\includegraphics[width=.7\textwidth]{../assets/reciprocal-leads.jpg}

#### Basic pathophys of STEMI
- Occurs due to proximal **complete occlusion of major coronary artery**

\includegraphics[width=.5\textwidth]{../assets/STEMI.jpg}

$$
\begin{aligned}
&\fbox{A. Before the onset of infarction}\\
&\downarrow\\
&\fbox{B. In acute phase, ST elevation}\\
&\downarrow\\
&\fbox{C. Progressive loss of R and deepening Q}\\
&\downarrow\\
&\fbox{D. Resolution of ST elevation; fully developed pathological Q;
T inversion}\\
&\downarrow\\
&\fbox{E. In old infarcts, T-wave inversion may or may not persist}\\
\end{aligned}
$$

- ST elevation resolves after a few days

\pagebreak

#### NSTEMI
- **Partial occlusion of major** or **complete occlusion of minor** coronary
 artery
- _Subendocardial/partial-thickness MI_ $\rightarrow$ **no pathological Q**
- **ST depression** + **T inversion** in chest leads

## Coronary Artery Disease
- Diseases arising due to narrowing of the lumen of one or more coronary
 arteries and the resulting ischaemia/infarction of the myocardium or
 the conductive system.
- **Types**:
	 - Stable angina: Fixed atheromatous stenosis
	 - Unstable angina:
	 	- dynamic obstruction
	 	- due to plaque rupture/erosion with thrombosis
	 - MI
	 - Heart failure
	 - Arrhythmia
	 - Sudden cardiac death
	 	- ventricular arrhythmia
	 	- asystole
	 	- massive MI

## Arrhythmias
### Classification according to ECG morphology
- **Narrow complex**: QRS < 120ms (3 small sqs)
	- Sinus tachycardia
	- Atrial fibrillation (irregular narrow complex tachycardia)
	- Atrial flutter
	- AV Nodal Re-entry Tachycardia (AVNRT aka SVT)

- **Broad complex**: QRS > 120ms (3 small sqs)
	- Ventricular tachycardia
	- AV Re-entry Tachycardia (AVRT e.g. Wolff-Parkinson-White syndrome)
		- Abnormal band of conductive tissue connecting atria and ventricles
		 (accessory pathway)

### Management of SVT
- Carotid sinus massage or
- Valsalva manoeuvre
- If the manoeuvre fails,
	- Adenosine (3-12mg IV) or
	- Rate-limiting CCB (Verapamil 5mg IV) or
	- $\beta$-blocker
- If haemodynamic state compromised, DC cardioversion
- Recurrent SVT $\rightarrow$ catheter ablation

## Atrial fibrillation
### Causes
- CAD (including acute MI)
- Mitral stenosis (MS; rheumatic mitral valve disease)
- Hypertension
- Thyrotoxicosis
- Cardiomyopathy
- Pulmonary embolism

### Investigations
- ECG
- Echo: to see valvular condition
- Thyroid function test: to exclude thyrotoxicosis

### Management of AF
- **Rhythm control**:
	- Pharmacological cardioversion
		- Pt stable + no history of heart disease $\rightarrow$ IV flecainide
		- Structural / ischaemic heart disease $\rightarrow$ IV amiodarone
	- DC cardioversion if drugs fail
- **Rate control**
	- $\beta$-blockers
	- Digoxin
	- Rate-limiting CCB: verapamil / diltiazem
- **Thromboprophylaxis:**
	- Oral Warfarin
	- Target INR: 2.0-3.0
	- Reduces risk of stroke by $\frac{2}{3}$
	- Start 4wks before cardioversion, continue till 3mo after successful
	 cardioversion

\pagebreak

## Myocardial Infarction

### Management of acute MI
\includegraphics[width=.7\textwidth]{../assets/MI-mx.png}

\pagebreak

# Dermatology
## Anatomy and physiology
- Layers of skin:
	- Epidermis: further layered into (from out$\rightarrow$in)
		- corneum
		- lucidum
		- granulosum
		- spinosum
		- basale
	- Dermis: contains
		- blood vessels
		- nerves
		- pilosebaceous units (hair follicle + sebaceous gland)
	- Subcutis: adipose

### Epidermal appendages
- Hair follicles:
	- phases of growth
		- anagen: 
			- active growth
			- lasts years in scalp hairs
		- catagen: 
			- transitional
			- lasts days (in scalp)
		- telogen: 
			- resting
			- lasts months (in scalp)
- Sebaceous glands
	- usually _associated with a hair follicle_
	- $\fbox{androgens}\rightarrow$ **$\uparrow$** $\fbox{sebum}$
	- $\fbox{oestrogen}\rightarrow$ **$\downarrow$** $\fbox{sebum}$
- Sweat glands
	- innerved by _sympathetic cholinergic_ fibres

## Principles of management of skin disease
### Topical treatments
- Ointments vs Creams
	- Ointments preferred to creams for dry skin (e.g. chronic eczema) as
		- more hydrating
			- 80% oil + 20% water in ointments (vs 50-50 for creams) $\rightarrow$
		 	prevent water loss from skin by oil layer
		- less preservatives $\rightarrow$ less risk of allergy
- Emollients
	- Moisturise, lubricate, protect skin
	- _Vehicles without active drug_
- Gluocorticoids

### Phototherapy
- **UVB**
- **Psoralen UVA**
	- Psoralen:
		- natural photosensitiser from plant source
		- cross-link DNA strands on excitation with UVA
	- Cumulative exposure to PUVA $\rightarrow\;\;\uparrow$
	 risk of SCC, so reserved for UVB resistance
- Uses
	- Psoriasis
	- Atopic eczema
	- Vitiligo
	- Chronic urticaria

### Systemics
- Antihistamines
- **Retinoids**
	- _Anti-inflammatory_
	- Promote _differentiation of skin cells_
	- **Teratogenic**
		- must be prescribed with robust contraception
		- females must have negative pregnancy test before, during, and after
		 therapy
- **Immunosuppressants**
	- Glucocorticoids e.g. prednisolone
	- Methotrexate
	- Azathioprine

### Biologics
- Biological _inhibitors_ of _proinflammatory cytokines_
- **TNF-$\alpha$ inhibitors**
	- Infliximab
	- Etanercept
- **Interleukin inhibitors**
	- Ustekinumab: IL-12, 23
	- Guselkumab: IL-23
	- Secukinumab: IL-17
- _Rituximab_:
	- Binds to CD20 $\rightarrow$ cause ADCC of B cells
	- As terminally differentiated plasma cells don't have CD20 they're safe
	- Use: pemphigus vulgaris

### Non-surgical therapy
- **Cryo**
	- _Liquid N$_2$_
	- Causes cell membrane destruction $\rightarrow$ death
- Laser
- PDT / photodynamic therapy

## Skin cancers
### Classification
- Non-melanoma skin cancer (NMSC): most common
	- SCC
	- BCC
- Melanoma
	- Less common
	- More metastatic risk $\rightarrow$ cause of most skin cancer deaths


## Fungal infections
### Types
- Superficial
	- Dermatophytes: aka **ringworm / tineasis**
		- _Trichophyton_
		- _Epidermophyton_
		- _Microsporum_
			
	- Yeast
- Deep: less common
	- Chromomycosis
	- Sporotrichosis

## Scabies
### Agent
Caused by the mite _Sarcoptis scabies hominis_

### Diagnosis
- Identify the skin burrow 
- Visualize the mite by dermatoscope / extracting with a needle

### Treatment
- Affected + all asymptomatic family members / physical contacts
- Topical permethrin / malathion
	- 2 applications
	- 1 wk apart
	- Whole body, except head
- Oral Ivermectin:
	- Single dose
	- For poor adherence, immunosuppresion or heavy infestation


## Acne
- _Chronic inflammation_ of _pilosebaceous_ units

### Pathogenesis
Key components are:

- $\uparrow$ Sebum production
- Colonisation of pilosebaceous ducts by _Propionibacterium acnes_
- Occlusion of pilosebaceous ducts

### Features
- Hallmark: **comedone**
- Greasiness of skin

### Management
- **Mild disease**
	- Topical Benzoyl peroxide
	- Topical Retinoids
	- Topical antibiotics
		- Erythromycin
		- Clindamycin
- **Moderate disease**: topical _plus_
	- Systemic tetracycline
	- Oestrogen containing OCP
	- Isotretinoin: if inadequate response to topical+systemic therapy
	 for 6 months
- **Severe disease**
	- Isotretinoin 0.5-1 mg/kg for 4 months:
		- Reduce sebum secretion and follicle colonisation
		- Teratogen
		- Pregnancy must be avoided during treatment _and_ within 2 mo of
		 drug cessation
	- Systemic glucocorticoid (with isotretinoin)
	- If unable to use isotretinoin
		- UVB phototherapy
		- PDT

\pagebreak

## Eczemas
- Seborrhoeic dermatitis is associated with _Malassezia_ yeasts

### Features
Most types have the following clinical features:

#### Acute
- Ill-defined erythema, oedema
- Papules, vesicles, bullae
- Exudation
- Scaling

#### Chronic
- Above features
- Lichenification
	- Skin thickening with pronounced skin markings, 2$^\circ$ to chronic
	 scratching
	- Fissures
	- Dyspigmentation

### Management of eczema
\includegraphics[width=.8\textwidth]{../assets/eczema.jpg}


\pagebreak

## Psoriasis
- Chronic inflammatory hyperproliferative skin disease
- **Characteristics**
	- **Well-defined erythematous scaly plaques**
	- Affecting **extensor surfaces, scalp, nails**

### Histological features
- Keratinocyte hyperproliferation + abnormal differentiation $\rightarrow$
 nucleated stratum corneum cells (transit time from basale to corneum reduced
 to 5 from 28 $\rightarrow$ keratinocytes reach the surface while immature)
- Inflammation with Th-1 and Th-17 infiltration
- Tortuosity of dermal capillaries and release of VEGF

### Exacerbating factors
- **Sunlight**
- **Trauma**
- **Infection**
	- $\beta$-haemolytic strep $\uparrow$ guttate psoriasis
	- HIV may initally present with severe psoriasis
- **Drugs**
	- Antimalarials
	- $\beta$-blockers
	- Lithium
	- NSAIDs
- **Stress and anxiety**

### Clinical types
- **Plaque** psoriasis:
	- most common
	- well-demarcated erythematous plaques
	- silver-white scales in untreated
		- bleed on scraping (due to dilated vessels underneath) $\rightarrow$
		 **Auspitz sign**
	- **Sites**
		- extensor surfaces
			- elbows
			- knees
			- lower back
		- scalp
		- nails
- **Guttate** psoriasis:
	- follows _Strep_ throat
	- common in children/adolescent
	- UVB highly effective
	- may herald the onset of plaque psoriasis in adulthood
- **Erythrodermic** sporiasis: generalised $\rightarrow$ medical emergency
- **Pustular** psoriasis

### Management of psoriasis
\includegraphics[width=.85\textwidth]{../assets/psoriasis.jpg}

\pagebreak
## Hypopigmentation
### Causes
- Vitiligo
- Albinism
- Pityriasis alba
- Pityriasis versicolor

### Vitiligo
- **Acquired**
- Cell-mediated **autoimmune destruction of melanocytes**
- Loss of melanocytes $\rightarrow$ hypopigmented patches

### Albinism
- **Autosomal recessive**
- **Reduced melanin production** by **normal number of melanocytes**
- $\uparrow\uparrow$ risk of sunburn, skin cancer

## Hyperpigmentation
### Causes
- **Endocrine**
	- Melasma/chloasma:
		- in pregnancy / some OCP users
		- discrete patches of facial pigmentation
	- Addison's disease
	- Cushing's syndrome
	- Nelson's syndrome
		- hyper-ACTH 2$^\circ$ to bilateral adrenalectomy for Cushing's
		- due to loss of -ve feedback from plasma cortisol
	- CKD
- **Drugs**
	- Amiodarone
	- Anti-cancers:
		- Bleomycin: Hodgkin's
		- Busulfan: CML
	- Choroquine
	- Psoralens


## Pseudorandom factoids
### SPF (sun protection factor)
- $\frac{\LARGE{\text{UV dose for producing erythema with sunscreen}}}
{\LARGE{\text{UV dose for producing erythema without sunscreen}}}$

### Mechanism of venous ulceration
\begin{center}
\fbox{Incompetent valves} \\
$\downarrow$ \\
\fbox{$\uparrow$ capillary pressure} \\
$\downarrow$ \\
\fbox{Fibrinogen leaks out of capillary} \\
$\downarrow$ \\
\fbox{Forms fibrin clot around capillary (pericapillary cuffing)} \\
$\downarrow$ \\
\fbox{Impaired diffusion from capillaries} \\
$\downarrow$ \\
\fbox{Impaired oxygenation}
\end{center}


\pagebreak

# Nephrology
## UTI
### Definition
Presence of > 10$^5$ organisms/mL in a mid-stream sample of urine.

### Features
- **LUTI**: cystitis/urethritis
	- Frequency
	- Urgency
	- Dysuria (burning urethral pain during micturition)
	- Haematuria
	- Strangury (intense desire to pass more urine after voiding, due to
	 spasm of inflamed bladder wall)
- **UUTI**: acute pyelonephritis
	- Fever with chills and rigor
	- Vomiting
	- Loin pain
	- Renal angle tenderness

### Commonly involved pathogens
- _E. coli_: 75%
- _Proteus_
- _Pseudomonas_
- _Streptococci_
- _Staph. epidermidis_


### Investigations
- Dipstick test for nitrites, leucocyte esterase, and glucose
	- Most urinary pathogens (e.g. _E. coli, Proteus_ etc) reduce nitrate to
	 nitrite
	- UTI $\rightarrow$ Neutrophils in urine $\rightarrow$ leucocyte esterase
- Microscopy for WBC and organisms
- Urine culture

### Treatment
#### Cystitis
- **1st choice**
	- **Trimethoprim** (200mg bds 3 days)
	- **Nitrofurantoin** (50mg qds 3 days)
- **Pregnancy**
	- Nitrofurantoin (50mg qds 7 days)
	- Cefalexin (250mg qds 7 days)
- Avoid trimethoprim during pregnancy, and nitrofurantoin at term

#### Pyelonephritis
- **1st choice**
	- **Cefalexin** (1g qds 14 days)
	- **Ciprofloxacin** (500mg bds 7 days)
- Hospitalise if no response within 24h

#### Epididymo-orchitis
- _1st choice_: Ciprofloxacin

#### Acute prostatitis
- _1st choice_: Trimethoprim

### Prophylactic measures in women with recurrent UTI
- Fluid intake $ge$ 2L/day
- Regular complete bladder evacuation
- Emptying the bladder before and after intercourse
- Good personal hygiene
- Continuous prophylactic trimethoprim (100mg) and nitrofurantoin (50 mg) at
 night

\pagebreak

# Neurology
## Raised ICP
- Normal ICP = **5-15 mmHg**

### Causes
- **ICSOL**
	- Intracranial haemorrhage
	- Tumours e.g. glioma
	- Brain abscess
- **Hydrocephalus**: blockade of CSF circulation
	- Obstructive / non-communicating
	- Communicating
- **Cerebral oedema** e.g. meningoencephilitis
- **Venous sinus obstruction** e.g. cerebral venous thrombosis

### Features
- **Headache**
- **Vomiting**
- **Diplopia / blurred vision**: Due to _6th nerve palsy_
	- 6th nerve palsy due to
		- stretching of the long, slender nerve
		- compression against petrous temporal bone
- **Papilloedema**
- **Bradycardia**
- **Hypertension**
- **Depressed consciousness**

### Management
- According to cause:
	- Mass lesion $\rightarrow$ surgical decompression
	- Hydrocephalus $\rightarrow$ _ventriculoperitoneal shunt_ operation
	- Oedema $\rightarrow$ glucocorticoids
- Supportive:
	- Head elevation
	- Fluid balance
	- BP control
	- Diuretics: mannitol

## Neurological emergencies
- **Status epilepticus**
- **Stroke** (if thrombo)
- **Subarachnoid haemorrhage**
- **Cord compression**
- **GBS**
- **Myasthenia gravis** (if bulbar and/or respiratory)

\pagebreak

## Status epilepticus
### Definition
Continuous or recurrent **seizures** for **$\ge$ 30 mins without gain of
 consciousness** in between.

### Management
\includegraphics[width=.7\textwidth]{../assets/stat-epi.png}




\pagebreak
